Opinion|Videos|September 30, 2024
Administration of FDA-Approved Fecal Microbiota Transplants for C. difficile Infections in Clinical Practice
Matthew D. Sims, MD, PhD, FACP, FIDSA, discusses how fecal microbiota transplantation therapies are administered and shares his clinical experience.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How are these FMT therapies administered?
- What has your experience been with administering each of these therapies?
- What have you heard from your patients?
Advertisement
Related to this article
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
Advertisement
Advertisement
Trending on Contagion Live
1
Ceftriaxone Safety: Separating Signal From Risk
2
A Pennsylvania Teen Dies From Rare Measles Neurological Complication
3
Revisiting Whether Cefepime Raises Mortality Risk
4
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
5